Severe ototoxicity in a health care worker who received postexposure prophylaxis with stavudine, lamivudine, and nevirapine after occupational exposure to HIV.
Rey
D
D
L'Héritier
A
A
Lang
J M
JM
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018890:Chemoprevention; D005260:Female; D015658:HIV Infections / Q000517:prevention & control; D006282:Health Personnel; D006311:Hearing Disorders / Q000139:chemically induced*; D006801:Humans; D019259:Lamivudine / Q000009:adverse effects* / Q000627:therapeutic use; D019829:Nevirapine / Q000009:adverse effects* / Q000627:therapeutic use; D016273:Occupational Exposure; D018119:Stavudine / Q000009:adverse effects* / Q000627:therapeutic use
D019380:Anti-HIV Agents; D019259:Lamivudine; D019829:Nevirapine; D018119:Stavudine